Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/120805
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoheimani, F.-
dc.contributor.authorKoops, J.-
dc.contributor.authorWilliams, T.-
dc.contributor.authorReid, A.T.-
dc.contributor.authorHansbro, P.M.-
dc.contributor.authorWark, P.A.-
dc.contributor.authorKnight, D.A.-
dc.date.issued2018-
dc.identifier.citationRespiratory Research, 2018; 19(1):145-1-145-16-
dc.identifier.issn1465-9921-
dc.identifier.issn1465-993X-
dc.identifier.urihttp://hdl.handle.net/2440/120805-
dc.description.abstractBackground: Specific microRNAs (miRNAs) play essential roles in airway remodeling in asthma. Infection with influenza A virus (IAV) may also magnify pre-existing airway remodeling leading to asthma exacerbation. However, these events remain to be fully defined. We investigated the expression of miRNAs with diverse functions including proliferation (miR-20a), differentiation (miR-22) or innate/adaptive immune responses (miR-132) in primary bronchial epithelial cells (pBECs) of asthmatics following infection with the H1N1 strain of IAV. Methods: pBECs from subjects (n = 5) with severe asthma and non-asthmatics were cultured as submerged monolayers or at the air-liquid-interface (ALI) conditions and incubated with IAV H1N1 (MOI 5) for up to 24 h. Isolated miRNAs were subjected to Taqman miRNAs assays. We confirmed miRNA targets using a specific mimic and antagomir. Taqman mRNAs assays and immunoblotting were used to assess expression of target genes and proteins, respectively. Results: At baseline, these miRNAs were expressed at the same level in pBECs of asthmatics and non-asthmatics. After 24 h of infection, miR-22 expression increased significantly which was associated with the suppression of CD147 mRNA and HDAC4 mRNA and protein expression in pBECs from non-asthmatics, cultured in ALI. In contrast, miR-22 remained unchanged while CD147 expression increased and HDAC4 remained unaffected in cells from asthmatics. IAV H1N1 mediated increases in SP1 and c-Myc transcription factors may underpin the induction of CD147 in asthmatics. Conclusion: The different profile of miR-22 expression in differentiated epithelial cells from non-asthmatics may indicate a self-defense mechanism against aberrant epithelial responses through suppressing CD147 and HDAC4, which is compromised in epithelial cells of asthmatics.-
dc.description.statementofresponsibilityFatemeh Moheimani, Jorinke Koops, Teresa Williams, Andrew T. Reid, Philip M. Hansbro, Peter A. Wark, and Darryl A. Knight-
dc.language.isoen-
dc.publisherSpringer Nature-
dc.rights© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.-
dc.source.urihttp://dx.doi.org/10.1186/s12931-018-0851-7-
dc.subjectSevere asthma; epithelial cells; microRNA; influenza A virus; airway remodeling-
dc.titleInfluenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics-
dc.typeJournal article-
dc.identifier.doi10.1186/s12931-018-0851-7-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1064405-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1079187-
pubs.publication-statusPublished-
dc.identifier.orcidMoheimani, F. [0000-0003-1239-3887]-
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_120805.pdfPublished Version2.18 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.